Skip to main content
Sign In
 


 

The Porter Lab is currently focused on developing novel therapeutic strategies for myeloid leukemias. We rely on functional genomics approaches to identify synthetic lethal interactions with conventional chemotherapeutics for AML, followed by detailed validation of "hits" using in vitro and in vivo models of leukemia. A major goal of our efforts is to translate these findings to patient care.

Recent Publications:

Journal Articles in Pub Med (www.pubmed.gov)